Skip to main content

Advertisement

SpringerLink
Log in

Influence of Cholestasis on Absorption of Ursodeoxycholic Acid

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Ursodeoxycholic acid (UDCA) has beneficialeffects in cholestatic liver diseases. Absorption ofUDCA is slow and incomplete. In the present study theeffect of cholestasis on absorption was evaluated in 10 patients with pancreatic carcinoma andextrahepatic biliary drainage. At days 3 and 10 afterinsertion of the biliary drain, all patients received750 mg UDCA in three divided doses. On both occasions intestinal absorption of UDCA was determined toevaluate the influence of cholestasis. Serum bilirubinwas used as indicator of cholestasis. Biliary output ofUDCA served as measure of absorption and was determined by gas-liquid chromatography. Atdays 4 and 11 bile consisted of less than 2% of UDCA,indicating that UDCA excretion was complete within 24 hrand no accumulation of UDCA had occurred. After insertion of the drain, serum bilirubindecreased from 12.2 ± 2.4 mg/dl at day 3 to 5.4± 0.9 mg/dl at day 10. Biliary secretion of bileacids increased from 2.0 ± 0.3 to 3.1 ±0.4 mmol/day, whereas percentage of ursodeoxycholic acid in bile didnot significantly increase (41.1% vs 42.1%). Absorptionof UDCA increased from 39.8 ± 5.0% to 61.1± 6.2% of the administered dose, indicating animprovement of the absorption rate after decrease ofcholestasis by 53.65% (P < 0.05). In conclusion, insevere cholestasis absorption of orally administeredUDCA is markedly reduced. This may have implications in the treatment of patients with cholestaticdisease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstern A, Gatzen M, Leuschner M: Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial. Gastroenterology 97:1268-1274, 1989

    Google Scholar 

  2. Poupon RE, Balkau B, Eschwege E, Poupon R: A multicenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 324:1548-1554, 1991

    Google Scholar 

  3. Combes B, Carithers RL, Maddrey WC, Lin D, McDonald MF, Wheeler DE, Eigenbrodt EH, Munoz SJ, Rubin R, Garcia-Tsao G, Bonner GF, West AB, Boyer JL, Luketic VA, Shiffman ML, Mills S, Peters MG, White HM, Zetterman RK, Rossi SS, Hofmann AF, Markin RS: A randomized, doubleblind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 22:759-766, 1995

    Google Scholar 

  4. Lindor KDL, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, Wiesner RH, Anderson ML, Lange SM, Lesage G, Rossi SS, Hofmann AF: Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 106:1284-1290, 1994

    Google Scholar 

  5. Heathcote EJL, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Papas SC, Scully LJ, Steinbrecher UP, Sutherland LR, Williams CN, Witt-Sullivan H, Worobetz LJ, Milner RA, Wanless IR: The Canadian multi-center double blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 19:1149-1156, 1994

    Google Scholar 

  6. Stiehl A, Raedsch R, Kommerell B: The effect of ursodeoxycholate in primary sclerosing cholangitis. A comparison to primary biliary cirrhosis. Gastroenterology 94:595, 1988; (Abstract)

    Google Scholar 

  7. Hayashi H, Hihucchi T, Ichimiya H, Hishida N, Sakamoto N: Symptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology 99:533-535, 1990

    Google Scholar 

  8. Chazouilleres O, Poupon R, Capron J-P, Metman E-H, Dhumeaux D, Amouretti M, Couzigou P, Labayle D, Trinchet J-C: Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol 11:120-123, 1990

    Google Scholar 

  9. O'Brien CB, Senior JR, Arora-Mirchandi R, Batta A, Salen G: Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30 months pilot study. Hepatology 14:838-847, 1991

    Google Scholar 

  10. Lebovics E, Salama M, Elhosseiny A, Rosenthal WS: Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis. Gastroenterology 102:2143-2147, 1992

    Google Scholar 

  11. Beuers U, Spengler U, Kruis W, Aydemir Ñ, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G: Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo controlled trial. Hepatology 16:707-714, 1992

    Google Scholar 

  12. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L: Effects of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3 year pilot study with a placebo-controlled study period. J Hepatol 20:57-64, 1994

    Google Scholar 

  13. Lindor KD, Mayo PSC/UDCA Study Group: Ursodiol for the treatment of primary sclerosing cholangitis. N Engl J Med 336:691-695, 1997

    Google Scholar 

  14. Mitchell SA, Bansi D, Hunt N, Christie J, Fleming K, Chapman R: High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomized double-blind, placebo-controlled trial. Gut 40( suppl1):TH 115, 1997; (abstract)

    Google Scholar 

  15. Stiehl A, Rudolph G, Sauer P, Benz C, Stremmel W, Walker S, Theilmann L: Efficacy of ursodeoxycholic acid and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-ye ar prospective study. J Hepatol 26:560-566, 1997

    Google Scholar 

  16. Palma J, Reyes H, Ribalta J, Iglesias J, Gonzalez MC, Hernandez I, Alvarez C, Molina C, Danitz AM: Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 15:1043-1047, 1992

    Google Scholar 

  17. Cotting J, Lentze MJ, Reichen J: Effects of ursodeoxycholic acid therapy on nutrition and liver function in patients with cystic fibrosis and long-standing cholestasis. Gut 31:918-921, 1990

    Google Scholar 

  18. Stiehl A, Raedsch R, Rudolph G: Acute effects of ursodeoxycholic acid and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology 98:424-428, 1990

    Google Scholar 

  19. Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, Eskreis D, Katz S: Effect of ursodeoxycholic acid on bile acid me tabolism in primary biliary cirrhosis. Hepatology 10:414-419, 1989

    Google Scholar 

  20. Stiehl A, Rudolph G, Raedsch R, Möller B, Hopf U, Lotterer E, Bircher J, Fölsch U, Klaus J, Endele R, Senn M: Ursode-oxycholic acid induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 12:492-497, 1990

    Google Scholar 

  21. Nakagawa M, Colombo C, Setchell KDR: Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 12:322-334, 1990

    Google Scholar 

  22. Crosignani A, Battezzati PM, Bertolini M, Zuin M, Watson D, Setchell KDR: Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 14:1000-1007, 1991

    Google Scholar 

  23. Poupon R, Chretien Y, Poupon R, Paumgartner G: Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy. Hepatology 17:599-604, 1993

    Google Scholar 

  24. Mazzella G, Parini P, Bazzoli F, et al: Ursodeoxycholic acid administration on bile acid metabolism in patients with early stage s of primary biliary cirrhosis. Dig Dis Sci 38:869-902, 1993

    Google Scholar 

  25. Sauer P, Fitscher BA, Klöters-Plachky P, Stremmel W, Stengelin S, Kramer W, Stiehl A: Effect of cholestasis on ileal and jejunal absorption of bile acids in rat. In Bile Acids in Hepatobiliary Diseases. Basic research and Clinical Application, G Paumgartner, A Stiehl, W Gerok (eds). Dordrecht, Kluwer, pp 188-191, 1996

    Google Scholar 

  26. Dumaswala R, Berkowitz D, Heubi JE: Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis. Hepatology 23:623-629, 1996

    Google Scholar 

  27. Stiehl A, Rudolph G, Sauer P, Theilmann L: Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment. J Hepatol 23:283-289, 1995

    Google Scholar 

  28. Stiehl A, Raedsch R, Rudolph G, Czygan P, Walker S: Analysis of bileacid glucuronides in urine: Group separation on a lipophilic anion exchanger. Clin Chim Acta 123:275-285, 1982

    Google Scholar 

  29. Alme B, Bremmelgaard A, Sjövall J, Thomassen P: Analysis of metabolic profiles of bile acid in urine using lipophilic anion exchanger and computerized gas liquid chromatography mass spectrometry. J Lipid Res 18:339-361, 1977

    Google Scholar 

  30. Walker S, Rudolph G, Raedsch R, Stiehl A: Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and biledrainage. Gastroenterology 102:810-815, 1992

    Google Scholar 

  31. Stiehl A, Raedsch R, Rudolph G: Ileal excretion of bile acids: comparison with biliary bile acid composition and effect of ursodeoxycholic acid treatment. Gastroenterology 94:1201-1206, 1988

    Google Scholar 

  32. Vlahcevic ZR, Heumann DM, Hylemon PB: Regulation of bile acid synthesis. Hepatology 13:590-600, 1991

    Google Scholar 

  33. Häussinger D, Hallbrucker C, Saha N, Lang F, Gerok W: Cell volume and bile acid excretion. Biochem J 288:681-689, 1992

    Google Scholar 

  34. Benedetti A, Strazzabosco M, Ng OC, Boyer JL: Regulation of activity and apical targeting of the Cl_ /HCO3 _ exchanger in rat hepatocytes. Proc Natl Acad Sci USA 91:792-796, 1994

    Google Scholar 

  35. Boyer JL, Soroka CJ: Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplet. Gastroenterology 109:1600-1611, 1995

    Google Scholar 

  36. Bruck R, Haddad P, Graf J, Boyer JL: Regulatory volume decrease stimulates bile flow, bile acid excretion, and exocytosis in isolated perfused rat liver. Am J Physiol 262:G806-G812, 1992

    Google Scholar 

  37. Beuers U, Nathanson MH, Isales CM, Boyer JL: Tauroursode-oxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca2+ mechanisms defective in cholestasis. J Clin Invest 92:2984-2993, 1993

    Google Scholar 

  38. Roda E, Mazzella G, Bazzoli F, Villanova N, Minutello A, Simoni P, Ronchi M, Poggi C, Festi D, Aldini R, Roda A: Effect of ursodeoxycholic acid administration in biliary lipid secretion in primary biliary cirrhosis. Dig Dis Sci 34:52S-58S, 1989

    Google Scholar 

  39. Nilsell K, Angelin B, Leijd B, Einarsson K: Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Gastroenterology 85:1248-1256, 1983

    Google Scholar 

  40. von Bergmann K, Epple-Gutsfeld M, Leiss O: Differences in the effects of chenodeoxycholic acid and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology 87:136-143, 1984

    Google Scholar 

  41. Mitchell SA, Bansi D, Hunt N, Christie J, Fleming K, Chapman R: High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): Results after two years of a randomized double-blind, placebo controlled trial. Gut 40( suppl 1):TH 115, 1997 (abstract)

    Google Scholar 

Download references

Authors
  1. Peter Sauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Benz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerda Rudolph
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Petra Kloters-Plachky
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wolfgang Stremmel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Adolf Stiehl
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sauer, P., Benz, C., Rudolph, G. et al. Influence of Cholestasis on Absorption of Ursodeoxycholic Acid. Dig Dis Sci 44, 817–822 (1999). https://doi.org/10.1023/A:1026686530785

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026686530785

Search

Navigation